ATE447713T1 - S100-proteine und -autoantikörper als serummarker für krebs - Google Patents

S100-proteine und -autoantikörper als serummarker für krebs

Info

Publication number
ATE447713T1
ATE447713T1 AT99960224T AT99960224T ATE447713T1 AT E447713 T1 ATE447713 T1 AT E447713T1 AT 99960224 T AT99960224 T AT 99960224T AT 99960224 T AT99960224 T AT 99960224T AT E447713 T1 ATE447713 T1 AT E447713T1
Authority
AT
Austria
Prior art keywords
cancer
subject
proteins
autoantibodies
screening methods
Prior art date
Application number
AT99960224T
Other languages
English (en)
Inventor
Samir Hanash
David Misek
Latha Prasanan
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of ATE447713T1 publication Critical patent/ATE447713T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4727—Calcium binding proteins, e.g. calmodulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT99960224T 1998-11-05 1999-11-05 S100-proteine und -autoantikörper als serummarker für krebs ATE447713T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10720998P 1998-11-05 1998-11-05
PCT/US1999/026226 WO2000026668A2 (en) 1998-11-05 1999-11-05 S100 proteins and autoantibodies as serum markers for cancer

Publications (1)

Publication Number Publication Date
ATE447713T1 true ATE447713T1 (de) 2009-11-15

Family

ID=22315443

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99960224T ATE447713T1 (de) 1998-11-05 1999-11-05 S100-proteine und -autoantikörper als serummarker für krebs

Country Status (9)

Country Link
US (1) US20020034773A1 (de)
EP (1) EP1125134B1 (de)
JP (1) JP4820003B2 (de)
AT (1) ATE447713T1 (de)
AU (1) AU773265B2 (de)
CA (1) CA2349593A1 (de)
DE (1) DE69941627D1 (de)
IL (1) IL142971A0 (de)
WO (1) WO2000026668A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US20030054414A1 (en) * 2001-09-17 2003-03-20 George Jackowski Diagnosis and treatment of early pre-type-1 diabetes utilizing glial fibrillary acidic protein
US7202045B2 (en) * 2001-09-19 2007-04-10 Regents Of The University Of Michigan Detection and treatment of cancers of the lung
AU2002367317A1 (en) 2001-12-31 2003-07-24 Dana-Farber Cancer Institute, Inc. Psoriasin expression by breast epithelial cells
AT412026B (de) * 2002-02-07 2004-08-26 Illmensee Karl Dr Verfahren zur diagnose eines zystischen ovarialkarzinoms
GB2395270B (en) * 2002-11-14 2006-08-16 Univ Nottingham Tumour marker proteins and uses thereof
GB0412620D0 (en) * 2004-06-05 2004-07-07 Univ Belfast BRCA1 markers
EP1778869B9 (de) 2004-07-23 2011-06-15 AspenBio Pharma, Inc. Verfahren und vorrichtungen zur diagnose von appendizitis
US7659087B2 (en) 2004-07-23 2010-02-09 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
PT1889059E (pt) 2005-05-27 2009-10-01 Oncimmune Ltd Métodos de imunoensaio melhorados
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
US8574848B2 (en) 2006-09-13 2013-11-05 Oncimmune Ltd. Immunoassay methods
CA2712505C (en) * 2008-01-17 2018-10-23 Fox Chase Cancer Center Biomarkers for the diagnosis and treatment of pancreatic cancer
RU2491291C2 (ru) * 2009-02-16 2013-08-27 Общество С Ограниченной Ответственностью "Герофарм" Модифицированный пептид и его использование для тестирования онкологических заболеваний цнс и эффективности терапии
US20130040839A1 (en) * 2011-06-27 2013-02-14 Ambergen, Inc. Method for Diagnosing or Determining the Prognosis of Colorectal Cancer (CRC) Using Novel Autoantigens: Gene Expression Guided Autoantigen Discovery
CN109856403A (zh) * 2018-12-21 2019-06-07 河北省医疗器械与药品包装材料检验研究院(河北省医疗器械技术审评中心) 一种S100-β蛋白时间分辨荧光免疫层析检测试剂盒
CN110873799A (zh) * 2019-12-09 2020-03-10 四川大学华西医院 Psmb4自身抗体检测试剂在制备肺癌筛查试剂盒中的用途
CN113138278A (zh) * 2020-01-19 2021-07-20 中国医学科学院肿瘤医院 S100a7蛋白作为标志物在食管鳞癌辅助诊断和预后判断中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3789413T2 (de) * 1986-10-03 1994-07-28 Ciba Geigy Ag Lymphokin-ähnliche Peptide.
CA2062675A1 (en) * 1991-04-09 1992-10-10 Sandra S. Fenton Endometrial antigen, composition, test kit and method for endometrial antibody determination
US5405749A (en) * 1991-12-06 1995-04-11 Polans; Arthur S. Method for identifying and purifying a cancer associated retinopathy autoantigen, and testing patient serum for the autoantibody to the autoantigen
RU2045759C1 (ru) * 1992-01-31 1995-10-10 Селифанова Ольга Петровна Способ скрининга нервно-психических заболеваний
CH685959A5 (de) * 1992-08-24 1995-11-15 Biomedicals Ag Diagnostische Testpackung zur Bestimmung von Proteinen.
JP2782695B2 (ja) * 1992-09-11 1998-08-06 ダムビノヴァ，スヴェトラーナ・アレクサンドロフナ 神経症および精神病の診断用免疫吸着剤およびその実際的用途
US5744144A (en) * 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
JPH07218509A (ja) * 1994-02-01 1995-08-18 Eiken Chem Co Ltd ヒト株化癌細胞と反応する血中癌特異抗体の測定法
RU2107913C1 (ru) * 1995-04-14 1998-03-27 Полетаев Александр Борисович Способ скринингового обследования женщин детородного возраста с помощью тест-системы eli-p для прогноза развития эмбриона/плода и рождения здорового либо аномального ребенка
SE9602677D0 (sv) * 1996-07-05 1996-07-05 Sangtec Medical Ab Methods for determining brain antigens
CA2280930C (en) * 1997-02-12 2010-04-06 The Regents Of The University Of Michigan Protein markers for lung cancer and use thereof
DE19707230C2 (de) * 1997-02-24 2000-01-13 Markus Otto Verfahren zum Erkennen einer Erkrankung eines Organismus an einer transmissiblen spongiformen Enzephalopathie
US5849528A (en) * 1997-08-21 1998-12-15 Incyte Pharmaceuticals, Inc.. Polynucleotides encoding a human S100 protein
US6150345A (en) * 1998-08-10 2000-11-21 Regents Of The University Of California Methods for promoting survival of myelin producing cells

Also Published As

Publication number Publication date
AU1714300A (en) 2000-05-22
DE69941627D1 (de) 2009-12-17
IL142971A0 (en) 2002-04-21
CA2349593A1 (en) 2000-05-11
WO2000026668A3 (en) 2000-09-08
EP1125134B1 (de) 2009-11-04
JP4820003B2 (ja) 2011-11-24
AU773265B2 (en) 2004-05-20
US20020034773A1 (en) 2002-03-21
JP2003517579A (ja) 2003-05-27
EP1125134A2 (de) 2001-08-22
WO2000026668A2 (en) 2000-05-11

Similar Documents

Publication Publication Date Title
DE69941627D1 (de) Für krebs
Oyaert et al. Semiquantitative, fully automated urine test strip analysis
Algeciras-Schimnich Thyroglobulin measurement in the management of patients with differentiated thyroid cancer
Tamaki et al. Wisteria floribunda agglutinin positive human Mac‐2‐binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients
EP0811162B1 (de) Verfahren zur diagnose gutartiger prostataerkrankungen
Lupoli et al. Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer
ATE312946T1 (de) Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten
ATE267399T1 (de) Verfahren zum nachweis von komplex-gebundenem prostata-spezifischem antigen (kpsa)
KR100679173B1 (ko) 위암 진단용 단백질 마커 및 이를 이용한 진단키트
US5994085A (en) Methods and devices for detecting non-complexed prostate specific antigen
WO2011085165A2 (en) Ca-125 immune complexes as biomarkers of ovarian cancer
RU2020127440A (ru) Способы, применения и наборы для диагностики заболеваний периодонта
WO2011074802A2 (ko) 전립선암 진단용 키트 및 진단방법
EP2784511A1 (de) Integrin-alpha-v-beta 6 zur Diagnose/Prognose von Kolorektalkarzinomen
KR102172016B1 (ko) 항-cyfra21-1 자가항체-항원 결합체 및 cyfra21-1 항원 마커의 검출방법 및 이들 마커의 비율을 이용한 폐암 진단키트
US10191048B2 (en) Fluorometric immunoassay for detection of anti-dsDNA antibodies
McGrath et al. Is there a role for an ultrasensitive thyroglobulin assay in patients with serum antithyroglobulin antibodies? A large (Australian) cohort study in differentiated thyroid cancer
KR102407703B1 (ko) 반려동물의 종양 질병을 보조적으로 진단하는 바이오마커 검사방법
CN120210363A (zh) 用于诊断晚期鼻咽癌的生物标志物及其应用
Partyka et al. Comparison of surgical and endoscopic sample collection for pancreatic cyst fluid biomarker identification
CN103698531B (zh) Rv1860、Rv0173和/或Rv1812c蛋白在制备诊断活动性肺结核的产品中的用途
CN106153923B (zh) 预测谷丙转氨酶小于二倍正常上限的慢性乙型病毒性肝炎患者肝脏炎症程度的系统
CN103698530B (zh) 结核分支杆菌蛋白在制备诊断活动性肺结核的产品中的用途
CA2366232A1 (en) Diagnosis of lysosomal storage disorders using saposins and other markers
US20200033349A1 (en) Methods and kits for predicting the risk of having or developping hepatocellular carcinoma in patients suffering from cirrhosis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties